Tulrampator is primarily investigated for its potential therapeutic applications in neurological and psychiatric disorders. It acts as an AMPA receptor modulator, which plays a crucial role in enhancing synaptic plasticity and cognitive function. Research has focused on its use in treating conditions such as depression, anxiety, and cognitive impairments associated with neurodegenerative diseases like Alzheimer's. By potentiating AMPA receptor activity, it may improve memory, learning, and overall brain function. Clinical trials are ongoing to evaluate its efficacy and safety in these areas, offering hope for new treatments in mental health and cognitive disorders.